المؤلفون: Haruki KOBAYASHI, Hideyuki HORISAWA, Hiroshi HOSOKAWA, Osamu YAMADA

المصدر: TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES, AEROSPACE TECHNOLOGY JAPAN. 2014, 12(ists29)25

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Table_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103038Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103038.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103038Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Figure_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103053Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103053.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103053Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Table_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103044Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103044.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103044Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103056Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103056.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103056Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Table_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103041Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103041.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103041Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Table_5_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103035Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103035.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_5_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103035Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Figure_1_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103062Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103062.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_1_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103062Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Figure_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103059Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103059.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103059Test

المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma

مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy

العلاقة: https://figshare.com/articles/journal_contribution/Supplemental_Methods_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103050Test

الإتاحة: https://doi.org/10.1158/2767-9764.25103050.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Methods_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103050Test